(Q51970600)

19 April 2018

meta-analysis

0 references

title

Course of cognitive decline in Parkinson's disease: a meta-analysis. (English)

1 reference

19 April 2018

0 references

1 reference

Dino Muslimović

1

1 reference

19 April 2018

Ben Schmand

series ordinal

2

1 reference

19 April 2018

Johannes D Speelman

series ordinal

3

1 reference

19 April 2018

Rob J de Haan

series ordinal

4

1 reference

19 April 2018

publication date

1 November 2007

1 reference

19 April 2018

Journal of the International Neuropsychological Society

published in

1 reference

19 April 2018

volume

13

1 reference

19 April 2018

issue

6

1 reference

19 April 2018

page(s)

920-932

1 reference

19 April 2018

Cognitive deficits in Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Change in cognitive function in idiopathic Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

A systematic review of cognitive decline in the general elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Progression of motor and cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

A longitudinal study of neuropsychological change in individuals with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Cognitive profile of patients with newly diagnosed Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

The rate of cognitive decline in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Issues associated with repeated neuropsychological assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

A 5-year longitudinal study of the Mini-Mental State Examination in normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

A neuropsychological comparison of demented and nondemented patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Relationship between cognitive impairments, event-related potentials, and motor disability scores in patients with Parkinson's disease: 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Risk factors for dementia in Parkinson's disease: effect of education.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Delirium in Parkinson's disease patients. a five-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson's disease over one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Clinical features predicting dementia in idiopathic Parkinson's disease: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Unilateral pallidotomy in PD: a controlled study of cognitive and behavioral effects. The Netherlands Pallidotomy Study (NEPAS) group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Neurobehavioral functioning in asymptomatic HIV-1 infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

Visuospatial impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

Which factors predict cognitive decline in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

How meta-analysis increases statistical power

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

Cognitive decline affects subject attrition in longitudinal research

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

Twelve-Month Follow-Up Study of Regional Cerebral Blood Flow in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

Practice effects on commonly used measures of executive function across twelve months

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

Cognitive impairments and depression in Parkinson's disease: a follow up study

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

A longitudinal study of visuospatial discrimination in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

Users' Guides to the Medical Literature

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

Verbal fluency deficits in Parkinson's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

Is there a specific visuo-spatial impairment in Parkinsonians?

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

What is cognitive reserve? Theory and research application of the reserve concept

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

Cognitive functioning after pallidotomy for refractory Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1355617707071160

7 January 2021

10.1017/S1355617707071160

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018